Literature DB >> 16099459

Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain.

Fumiaki Yokoi1, Mai T Dang, Shinichi Mitsui, Yuqing Li.   

Abstract

Mutations of SGCE encoding epsilon-sarcoglycan cause myoclonus-dystonia. SGCE is paternally expressed; however, 5-10% of patients show maternal inheritance of the disease. We found Sgce was exclusively paternally expressed in mice by using a novel polymorphism marker. The result was confirmed in Sgce heterozygous knockout mice. This finding suggests that maternally inherited myoclonus-dystonia may not result from maternal expression of SGCE. Furthermore, we report a new family of alternatively spliced Sgce mRNA expressed in the brain coding for different C-terminal sequences possessing a PDZ-binding motif. Our results provide a better basis for diagnosis and understanding of the pathogenesis of myoclonus-dystonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099459     DOI: 10.1016/j.febslet.2005.07.065

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

2.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

3.  Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce.

Authors:  Fumiaki Yokoi; Guang Yang; Jindong Li; Mark P DeAndrade; Tong Zhou; Yuqing Li
Journal:  J Biochem       Date:  2010-07-13       Impact factor: 3.387

4.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

Review 5.  What does genetics tell us about imprinting and the placenta connection?

Authors:  Susannah Varmuza; Kamelia Miri
Journal:  Cell Mol Life Sci       Date:  2014-09-07       Impact factor: 9.261

6.  Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Guang Yang; Jindong Li; Atbin Doroodchi; Tong Zhou; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-21       Impact factor: 3.332

7.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

8.  SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?

Authors:  Katja Ritz; Barbera Dc van Schaik; Marja E Jakobs; Antoine H van Kampen; Eleonora Aronica; Marina A Tijssen; Frank Baas
Journal:  Eur J Hum Genet       Date:  2010-12-15       Impact factor: 4.246

9.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

Review 10.  ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.

Authors:  Ana Cazurro-Gutiérrez; Anna Marcé-Grau; Marta Correa-Vela; Ainara Salazar; María I Vanegas; Alfons Macaya; Àlex Bayés; Belén Pérez-Dueñas
Journal:  Mol Neurobiol       Date:  2021-04-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.